Giving Back Control to Patients with Uncontrolled Epilepsy

Research Context and Background

Epilepsy affects approximately 65 million people around the world. For many of these individuals, the condition remains uncontrolled, leading to severe complications and a lower quality of life. A major concern for patients with uncontrolled seizures is Sudden Unexpected Death in Epilepsy, often called SUDEP. Current data shows that 70% of these tragic cases happen during sleep. Sadly, no existing device effectively monitors the risk of SUDEP because detecting a seizure alone is often not enough to prevent these outcomes.

What is Neurava

Neurava is developing a unique platform designed to help people with epilepsy take back control of their lives. The company built this solution based on research that found a strong link between SUDEP and heart or breathing problems caused by seizures. Neurava created a complete monitoring system to address this gap.

The Neurava ecosystem has four main parts that work together to provide full monitoring and useful insights:

1. The A1 Seizure Sensor: This device records and alerts for convulsive seizures using a special sensing array with top-tier performance.
2. The N1 Cardiorespiratory Sensor: This sensor captures heart rate, breathing, and oxygen levels. It alerts users if these signals move outside normal ranges.
3. Mobile App: This app uses AI to constantly check incoming data. It gives high-confidence alerts for potential events and lets users manage medication history, add notes, and view reports.
4. Physician Portal: This tool is for healthcare professionals. It gives them detailed insights into past data so they can manage care based on facts.

Benefits

Neurava offers several key advantages for patients and their families:

• Holistic Monitoring:Unlike other devices that only watch for seizures, Neurava tracks both seizure activity and heart and breathing health. This provides a complete picture of the patient’s condition.
• Predictive Capabilities:The system aims to not just detect events but also predict them. This allows for a better understanding of SUDEP risk.
• Comfort and Wearability:Early users report that the devices are very comfortable. Many say they do not feel heavy and are easy to wear even while sleeping. This is crucial for getting accurate data without disturbing the patient.
• Actionable Alerts:If a critical event is detected, the system sends instant alerts to caregivers and emergency services. This ensures help can arrive quickly if needed.
• Data-Driven Care:The physician portal gives doctors detailed information. This helps medical teams make better decisions about treatment plans.

Use Cases

Neurava is designed for individuals with epilepsy who struggle with uncontrolled seizures and want to reduce their risk of SUDEP. The primary use case is nighttime monitoring.

• Sleep Tracking:The system runs while the patient sleeps. It tracks seizure activity and cardiorespiratory signals simultaneously. This is vital because most SUDEP cases occur during sleep.
• Home Monitoring:Patients can wear the devices at home. The comfortable design allows for long-term use without causing skin irritation or discomfort.
• Caregiver Support:Family members receive alerts if something goes wrong. This gives them peace of mind and the ability to respond immediately.
• Medical Management:Doctors use the data from the physician portal to review trends over time. This helps them adjust medications or treatments to better control the patient’s condition.

Pricing

Pricing details for Neurava are not available in the provided information.

Vibes

Early adopters and patients have responded very positively to the technology. Here is what some users have said:

• Effectiveness:One 37-year-old individual with epilepsy said, "This is an awesome invention. I believe this could help so many patients... I’m glad that I chose to wear this device it could very well help others."
• Family Support:A parent of a 12-year-old child with epilepsy stated, "My thought is this device is fantastic and very helpful. I would definitely have my child wear it at home for seizure monitoring... Thank you for the opportunity and we hope this monitoring continues to be a great success!"
• Comfort:An 18-year-old user noted, "I love this one. You don’t really notice it, which I like. It doesn’t feel heavy or anything like that. I have sensitive skin and the fact that it doesn’t bother my skin is fantastic! Much more comfortable to have on."
• Sleep Tracking:A 34-year-old user mentioned, "Helps at night when tracking when sleeping and that’s my main worries. Its not annoying, can barely tell it was on. would <3 it!! would love to take one home to keep track when I am asleep."

Additional Information

Neurava has strong industry support. Colin Lake, Head of Digital Business at UCB, stated that UCB is proud to support Neurava. He noted that studies suggest roughly one out of every 1,000 deaths in the U.S. are a result of SUDEP every year. He added that Neurava’s smart wearables are the first of their kind and have the potential to save lives in the future. This partnership highlights the company’s alignment with broader efforts to reduce mortality rates associated with epilepsy.